- Home
- LNTH vs S Comparison
LNTH vs S Comparison
Compare LNTH & S Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- S
- Stock Information
- Founded
- LNTH 1956
- S 2013
- Country
- LNTH United States
- S United States
- Employees
- LNTH N/A
- S N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- S EDP Services
- Sector
- LNTH Health Care
- S Technology
- Exchange
- LNTH Nasdaq
- S Nasdaq
- Market Cap
- LNTH 7.5B
- S 6.0B
- IPO Year
- LNTH 2015
- S 2021
- Fundamental
- Price
- LNTH $79.19
- S $17.38
- Analyst Decision
- LNTH Strong Buy
- S Buy
- Analyst Count
- LNTH 5
- S 30
- Target Price
- LNTH $133.80
- S $24.77
- AVG Volume (30 Days)
- LNTH 1.0M
- S 7.6M
- Earning Date
- LNTH 07-30-2025
- S 05-28-2025
- Dividend Yield
- LNTH N/A
- S N/A
- EPS Growth
- LNTH N/A
- S N/A
- EPS
- LNTH 3.53
- S N/A
- Revenue
- LNTH $1,536,699,000.00
- S $864,135,000.00
- Revenue This Year
- LNTH $4.63
- S $24.05
- Revenue Next Year
- LNTH $9.35
- S $20.71
- P/E Ratio
- LNTH $22.44
- S N/A
- Revenue Growth
- LNTH 12.53
- S 28.19
- 52 Week Low
- LNTH $73.11
- S $15.36
- 52 Week High
- LNTH $126.89
- S $29.29
- Technical
- Relative Strength Index (RSI)
- LNTH 44.57
- S 40.19
- Support Level
- LNTH $76.34
- S $17.22
- Resistance Level
- LNTH $84.36
- S $17.88
- Average True Range (ATR)
- LNTH 2.69
- S 0.55
- MACD
- LNTH 0.66
- S -0.07
- Stochastic Oscillator
- LNTH 48.07
- S 25.23
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About S SentinelOne Inc.
SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.